Effectiveness of antiretroviral therapy in treatment-naïve patients. Results at 24 and 48 weeks

Effectiveness of antiretroviral therapy in treatment-naïve patients. Results at 24 and 48 weeks

Bibliographic Details
Main Authors:	Ana Gomez-Lobon, Joaquin Serrano Lopez De Las Hazas, Francisco Javier Fanjul Losa, Pilar Rovira Torres, Ana Vanrell Ballesteros, Antonio Payeras Cifre, Melchor Riera Jaume
Format:	Article
Language:	English
Published:	Termedia Publishing House 2019-07-01
Series:	HIV & AIDS Review. International Journal of HIV-Related Problems
Subjects:	adult anti-hiv agents hiv infections treatment outcome viral load
Online Access:	https://www.termedia.pl/Effectiveness-of-antiretroviral-therapy-in-treatment-naive-patients-Results-at-24-and-48-weeks,106,37099,1,1.html

Similar Items

DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)
by: Carmen Hidalgo-Tenorio, et al.
Published: (2022-03-01)

Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study
by: Bih Hycenta Chendi, et al.
Published: (2019-02-01)

Seguimiento del primer año de tratamiento antirretroviral en pacientes naive en un hospital de tercer nivel
by: Ana Gomez-Lobona, et al.

Characterization of virologic failure after an initially successful 48-week course of antiretroviral therapy in HIV/AIDS outpatients treated in Santos, Brazil
by: Marcos M. Caseiro, et al.

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
by: Tony Antoniou, et al.
Published: (2017-04-01)

Anemia in Antiretroviral Naïve HIV/AIDS Patients: A Study from Eastern India
by: Arindam Pande, et al.
Published: (2012-01-01)

Prevalence of antiretroviral drug resistance among treatment-naive and treated HIV-infected patients in Venezuela
by: Héctor Rafael Rangel, et al.
Published: (2009-05-01)

Prevalence of hypertension among antiretroviral therapy naïve patients in Lagos, Nigeria
by: Oluwatosin Odubela, et al.
Published: (2023-11-01)

Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection
by: Vasiliki Chounta, et al.
Published: (2022-05-01)

Iron intake is positively associated with viral load in antiretroviral naïve Brazilian men living with HIV
by: Juliana Lauar Gonçalves, et al.
Published: (2020-01-01)

Absence of HIV-Associated Nephropathy Among Antiretroviral Naive Adults With Persistent Albuminuria in Western Kenya
by: M.K. Koech, et al.
Published: (2017-03-01)

HIV antiretroviral preexposure prophylaxis
by: Richard Tjan
Published: (2015-12-01)

Comparison of Immunological and Virological Recovery with Rapid, Early, and Late Start of Antiretroviral Treatment in Naive Plwh: Real-World Data
by: Sarıgül Yıldırım F, et al.
Published: (2023-05-01)

Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China
by: Min Li, et al.
Published: (2023-11-01)

Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life
by: Barbara Laughton, et al.
Published: (2019-10-01)

Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study
by: Birkneh Tilahun Tadesse, et al.
Published: (2019-09-01)

Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study
by: Fricke Ulrich, et al.
Published: (2012-01-01)

Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART) - naïve patients
by: Akinsegun Akinbami, et al.
Published: (2012-07-01)

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
by: Patruno Savino FA, et al.
Published: (2002-08-01)

Impact of micronutrients on the psychological well-being of highly active antiretroviral therapy-naïve human immunodeficiency virus-infected patients
by: Victor Obiajulu Olisah, et al.
Published: (2020-01-01)

Incidence of Bacteremia in Antiretroviral-naive HIV-positive Children Less Than Five Years of Age in Benin City-Nigeria
by: Imade PE, et al.
Published: (2010-01-01)

Caregiver's burden of children living with HIV on antiretroviral therapy at an urban setup
by: Shivangi Ashvinbhai Inamdar, et al.
Published: (2021-01-01)

Study of bone marrow changes in antiretroviral naive human immunodeficiency virus-infected anemic patients
by: Arindam Pande, et al.
Published: (2011-01-01)

Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study
by: Esser S, et al.
Published: (2011-10-01)

Same Week: Feasibility of Rapid Antiretroviral Initiation in Brazil
by: Elaine Monteiro Matsuda, et al.
Published: (2021-01-01)

HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE
by: Jane R. Millar, et al.
Published: (2020-05-01)

The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy
by: Sara Rodrigues Fernandes, et al.
Published: (2023-08-01)

Enteric parasitic infection among antiretroviral therapy Naïve HIV-seropositive people: Infection begets infection-experience from Eastern India
by: Suman Mitra, et al.
Published: (2016-01-01)

Drug-selective pressure effect on HIV integrase mutations in antiretroviral naïve and experienced patients
by: Parya Basimi, et al.
Published: (2023-04-01)

Response of HIV-associated proteinuria to antiretroviral therapy in HIV-1-infected children
by: Ira Shah

Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study
by: Salvatore Martini, et al.
Published: (2022-12-01)

Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy
by: Yuyang Tang, et al.
Published: (2023-06-01)

HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
by: Deanna A. Kulpa, et al.
Published: (2015-04-01)

Guidelines for antiretroviral therapy in adults
by: G Meintjes, et al.
Published: (2012-08-01)

Do disability grants influence adherence to antiretroviral therapy?
by: Ashraf Kagee
Published: (2014-04-01)

Predictors of SIV recrudescence following antiretroviral treatment interruption
by: Mykola Pinkevych, et al.
Published: (2019-10-01)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Clinical Outcomes of Multidisciplinary Team Approach in Naïve HIVInfected Patients on Antiretroviral Therapy at Infectious Diseases Out-patient Clinic, Songklanagarind Hospital
by: Piengjai Kiettanawattana, et al.
Published: (2014-06-01)

Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco
by: Ana Maria Salustiano Cavalcanti, et al.
Published: (2012-06-01)

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
by: Adele S. Benzaken, et al.
Published: (2019-08-01)